Balance Sheet

Accounts Payables Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

BioNTech SE (BNTX) Shareholder's Equity (2018 - 2021)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	595,226.00
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	14.38 Mn
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	19.36 Bn
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	31.42 Bn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	1.08 Bn
10	BioNTech SE	27.66 Bn	7.53 Bn	668.28 Mn	-

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2021	13.61 Bn
Dec 31, 2020	1.64 Bn
Dec 31, 2019	546.25 Mn
Dec 31, 2018	304.75 Mn